Lysosome-targeting chimera (LYTAC): A silver bullet for targeted degradation of oncogenic membrane proteins

Qingquan Zheng; Jiawei Guo; Rui Ma; Wenchen Pu

doi:10.1002/mog2.64

MEDCOMM - Oncology ›› 2023, Vol. 3 ›› Issue (1) : 64 DOI: 10.1002/mog2.64

HIGHLIGHT

Lysosome-targeting chimera (LYTAC): A silver bullet for targeted degradation of oncogenic membrane proteins

Qingquan Zheng ¹
, Jiawei Guo ¹
, Rui Ma ²
, Wenchen Pu ¹^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Qingquan Zheng, Jiawei Guo, Rui Ma, Wenchen Pu. Lysosome-targeting chimera (LYTAC): A silver bullet for targeted degradation of oncogenic membrane proteins. MEDCOMM - Oncology, 2023, 3(1): 64 DOI:10.1002/mog2.64

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

RIGHTS & PERMISSIONS

2023 The Authors. MedComm – Oncology published by John Wiley & Sons Australia, Ltd on behalf of Sichuan International Medical Exchange & Promotion Association (SCIMEA).